279 related articles for article (PubMed ID: 15133994)
1. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
[TBL] [Abstract][Full Text] [Related]
2. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
3. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
4. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
Zaprianova E; Deleva D; Bakalska M; Filchev N
Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
[TBL] [Abstract][Full Text] [Related]
5. Pathological findings in rats with experimental allergic encephalomyelitis.
Dong M; Liu R; Guo L; Li C; Tan G
APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
[TBL] [Abstract][Full Text] [Related]
6. Effects of amphetamine and cocaine on the development of acute experimental allergic encephalomyelitis in Lewis rats.
Núñez MJ; Balboa J; Rey-Méndez M; Brenlla J; González-Peteiro M; Rodrigo E; Freire-Garabal M
Hum Exp Toxicol; 2007 Aug; 26(8):637-43. PubMed ID: 17884951
[TBL] [Abstract][Full Text] [Related]
7. [Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis].
Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
No To Shinkei; 1990 Apr; 42(4):391-7. PubMed ID: 1697182
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte targeting of the brain in adoptive transfer cryolesion-EAE.
Lake J; Weller RO; Phillips MJ; Needham M
J Pathol; 1999 Jan; 187(2):259-65. PubMed ID: 10365103
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
10. Role of cervical lymph nodes in autoimmune encephalomyelitis in the Lewis rat.
Phillips MJ; Needham M; Weller RO
J Pathol; 1997 Aug; 182(4):457-64. PubMed ID: 9306968
[TBL] [Abstract][Full Text] [Related]
11. Possible role of ependymal proliferation in improving experimental allergic encephalomyelitis in Lewis rats.
Mohamed A; Yunus M; Hamadain E; Benghuzzi H
Biomed Sci Instrum; 2006; 42():405-9. PubMed ID: 16817642
[TBL] [Abstract][Full Text] [Related]
12. Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia.
Melanson M; Miao P; Eisenstat D; Gong Y; Gu X; Au K; Zhu W; Begum F; Frost EE; Namaka M
Mult Scler; 2009 Oct; 15(10):1135-45. PubMed ID: 19667008
[TBL] [Abstract][Full Text] [Related]
13. Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats.
Quintanar-Stephano A; Chavira-Ramírez R; Kovacs K; Berczi I
J Endocrinol; 2005 Jan; 184(1):51-8. PubMed ID: 15642782
[TBL] [Abstract][Full Text] [Related]
14. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of experimental allergic encephalitis (EAE) through phase 2 enzyme induction.
Mohamed AA; Avila JG; Schültke E; Kamencic H; Skihar V; Obayan A; Juurlink BH
Biomed Sci Instrum; 2002; 38():9-13. PubMed ID: 12085664
[TBL] [Abstract][Full Text] [Related]
17. Improved detectability of experimental allergic encephalomyelitis in excised swine spinal cords by high b-value q-space DWI.
Biton IE; Mayk A; Kidron D; Assaf Y; Cohen Y
Exp Neurol; 2005 Oct; 195(2):437-46. PubMed ID: 16098966
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor prevents demyelination, cell death and progression of the disease in experimental allergic encephalomyelitis.
Parvaneh Tafreshi A
Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):177-81. PubMed ID: 17237570
[TBL] [Abstract][Full Text] [Related]
19. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats.
Hoffman GE; Le WW; Murphy AZ; Koski CL
Exp Neurol; 2001 Oct; 171(2):272-84. PubMed ID: 11573979
[TBL] [Abstract][Full Text] [Related]
20. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
Whitacre CC; Paterson PY
J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
